These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 35673837)
1. [Therapy of Heart Failure with Reduced Ejection Fraction: What's New in the 2021 Guidelines?]. Maeder MT; Rickli H; Brenner R; Scheler E; Buser M Praxis (Bern 1994); 2022; 111(8):445-456. PubMed ID: 35673837 [TBL] [Abstract][Full Text] [Related]
2. [A practical approach to guideline-directed pharmacological treatment for heart failure with reduced ejection fraction]. Soltani S; Böhm M; Frey N; Eden M; Abdin A; Bauersachs J Dtsch Med Wochenschr; 2022 Jul; 147(14):931-938. PubMed ID: 35868319 [TBL] [Abstract][Full Text] [Related]
3. Tailoring guideline-directed medical therapy in heart failure with reduced ejection fraction: A practical guide. Kapłon-Cieślicka A; Vardas P; Grabowski M; Lelonek M Kardiol Pol; 2023; 81(9):850-858. PubMed ID: 37794739 [TBL] [Abstract][Full Text] [Related]
4. Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction. Butler J; Yang M; Manzi MA; Hess GP; Patel MJ; Rhodes T; Givertz MM J Am Coll Cardiol; 2019 Mar; 73(8):935-944. PubMed ID: 30819362 [TBL] [Abstract][Full Text] [Related]
5. Impact of Individual Patient Profiles on Adherence to Guideline Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: VCOR-HF Study. Driscoll A; Dinh D; Wong J; Hopper I; Mariani J; Zimmet H; Brennan A; Lefkovits J; Carruthers H; Reid CM Heart Lung Circ; 2020 Dec; 29(12):1782-1789. PubMed ID: 32646638 [TBL] [Abstract][Full Text] [Related]
6. Sequencing and titrating approach of therapy in heart failure with reduced ejection fraction following the 2021 European Society of Cardiology guidelines: an international cardiology survey. Fauvel C; Bonnet G; Mullens W; Giraldo CIS; Mežnar AZ; Barasa A; Tokmakova M; Shchendrygina A; Costa FM; Mapelli M; Zemrak F; Tops LF; Jakus N; Sultan A; Bahouth F; Hadjseyd CE; Salvat M; Anselmino M; Messroghli D; Weberndörfer V; Giverts I; Bochaton T; Courand PY; Berthelot E; Legallois D; Beauvais F; Bauer F; Lamblin N; Damy T; Girerd N; Sebbag L; Pezel T; Cohen-Solal A; Rosano G; Roubille F; Mewton N Eur J Heart Fail; 2023 Feb; 25(2):213-222. PubMed ID: 36404398 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacological therapy of heart failure with reduced ejection fraction]. Wieser M; Rhyner D; Martinelli M; Suter T; Schnegg B; Bösch C; Wigger O; Dobner S; Hunziker L Ther Umsch; 2018 Sep; 75(3):180-186. PubMed ID: 30145973 [TBL] [Abstract][Full Text] [Related]
8. Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology. Mewton N; Girerd N; Boffa JJ; Courivaud C; Isnard R; Juillard L; Lamblin N; Legrand M; Logeart D; Mariat C; Meune E; Sabouret P; Sebbag L; Rossignol P Arch Cardiovasc Dis; 2020 Oct; 113(10):660-670. PubMed ID: 32660835 [TBL] [Abstract][Full Text] [Related]
9. Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: Results from TSOC-HFrEF registry. Chang HY; Wang CC; Wei J; Chang CY; Chuang YC; Huang CL; Chong E; Lin JL; Mar GY; Chan KC; Kuo JY; Wang JH; Chen ZC; Tseng WK; Cherng WJ; Yin WH J Chin Med Assoc; 2017 Dec; 80(12):750-757. PubMed ID: 29033112 [TBL] [Abstract][Full Text] [Related]
10. Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry. Vaduganathan M; Fonarow GC; Greene SJ; DeVore AD; Kavati A; Sikirica S; Albert NM; Duffy CI; Hill CL; Patterson JH; Spertus JA; Thomas LE; Williams FB; Hernandez AF; Butler J JACC Heart Fail; 2020 Jun; 8(6):469-480. PubMed ID: 32387066 [TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center. Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333 [TBL] [Abstract][Full Text] [Related]
13. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Verma S; Dhingra NK; Butler J; Anker SD; Ferreira JP; Filippatos G; Januzzi JL; Lam CSP; Sattar N; Peil B; Nordaby M; Brueckmann M; Pocock SJ; Zannad F; Packer M; Lancet Diabetes Endocrinol; 2022 Jan; 10(1):35-45. PubMed ID: 34861154 [TBL] [Abstract][Full Text] [Related]
14. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry. Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ; JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482 [TBL] [Abstract][Full Text] [Related]
15. New pharmacotherapy for heart failure with reduced ejection fraction. Sotirakos S; Wheen P; Spiers J; Armstrong R Expert Rev Cardiovasc Ther; 2020 Jul; 18(7):405-414. PubMed ID: 32546023 [TBL] [Abstract][Full Text] [Related]
16. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial. Srivastava PK; Claggett BL; Solomon SD; McMurray JJV; Packer M; Zile MR; Desai AS; Rouleau JL; Swedberg K; Fonarow GC JAMA Cardiol; 2018 Dec; 3(12):1226-1231. PubMed ID: 30484837 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment options for heart failure with reduced ejection fraction: A 2022 update. Hellenkamp K; Nolte K; von Haehling S Expert Opin Pharmacother; 2022 Apr; 23(6):673-680. PubMed ID: 35260016 [TBL] [Abstract][Full Text] [Related]
18. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry. Greene SJ; Butler J; Albert NM; DeVore AD; Sharma PP; Duffy CI; Hill CL; McCague K; Mi X; Patterson JH; Spertus JA; Thomas L; Williams FB; Hernandez AF; Fonarow GC J Am Coll Cardiol; 2018 Jul; 72(4):351-366. PubMed ID: 30025570 [TBL] [Abstract][Full Text] [Related]
19. Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology. Mullens W; Martens P; Testani JM; Tang WHW; Skouri H; Verbrugge FH; Fudim M; Iacoviello M; Franke J; Flammer AJ; Palazzuoli A; Barragan PM; Thum T; Marcos MC; Miró Ò; Rossignol P; Metra M; Lassus J; Orso F; Jankowska EA; Chioncel O; Milicic D; Hill L; Seferovic P; Rosano G; Coats A; Damman K Eur J Heart Fail; 2022 Apr; 24(4):603-619. PubMed ID: 35239201 [TBL] [Abstract][Full Text] [Related]
20. [European guidelines on heart failure: pharmacotherapy]. Grundmann S; von Zur Mühlen C Herz; 2023 Mar; 48(2):89-94. PubMed ID: 36695878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]